| Product NDC: | 15955-327 |
| Proprietary Name: | LEVETIRACETAM |
| Non Proprietary Name: | LEVETIRACETAM |
| Active Ingredient(s): | 100 mg/mL & nbsp; LEVETIRACETAM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 15955-327 |
| Labeler Name: | Orit Laboratories LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203067 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120430 |
| Package NDC: | 15955-327-16 |
| Package Description: | 473 mL in 1 BOTTLE, PLASTIC (15955-327-16) |
| NDC Code | 15955-327-16 |
| Proprietary Name | LEVETIRACETAM |
| Package Description | 473 mL in 1 BOTTLE, PLASTIC (15955-327-16) |
| Product NDC | 15955-327 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LEVETIRACETAM |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20120430 |
| Marketing Category Name | ANDA |
| Labeler Name | Orit Laboratories LLC |
| Substance Name | LEVETIRACETAM |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |